Cubist Systematic Strategies’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
+29,967
| New | +$115K | ﹤0.01% | 1289 |
|
|
2024
Q1 | – | Sell |
-12,138
| Closed | -$42.6K | – | 2178 |
|
|
2023
Q4 | $42.6K | Sell |
12,138
-2,795
| -19% | -$9.81K | ﹤0.01% | 1874 |
|
|
2023
Q3 | $99.8K | Buy |
+14,933
| New | +$99.8K | ﹤0.01% | 1636 |
|
|
2023
Q2 | – | Sell |
-5,757
| Closed | -$57.2K | – | 2237 |
|
|
2023
Q1 | $57.2K | Buy |
+5,757
| New | +$57.2K | ﹤0.01% | 2509 |
|
|
2022
Q4 | – | Sell |
-116,285
| Closed | -$621K | – | 3241 |
|
|
2022
Q3 | $621K | Buy |
116,285
+23,988
| +26% | +$128K | ﹤0.01% | 2369 |
|
|
2022
Q2 | $368K | Buy |
92,297
+78,312
| +560% | +$312K | ﹤0.01% | 2810 |
|
|
2022
Q1 | $62K | Sell |
13,985
-70,357
| -83% | -$312K | ﹤0.01% | 3314 |
|
|
2021
Q4 | $337K | Buy |
84,342
+41,090
| +95% | +$164K | ﹤0.01% | 2719 |
|
|
2021
Q3 | $380K | Sell |
43,252
-77,597
| -64% | -$682K | ﹤0.01% | 2211 |
|
|
2021
Q2 | $1.37M | Buy |
120,849
+37,732
| +45% | +$427K | 0.02% | 1354 |
|
|
2021
Q1 | $987K | Buy |
83,117
+58,860
| +243% | +$699K | 0.01% | 1549 |
|
|
2020
Q4 | $166K | Buy |
24,257
+23,102
| +2,000% | +$158K | ﹤0.01% | 2310 |
|
|
2020
Q3 | $9K | Buy |
+1,155
| New | +$9K | ﹤0.01% | 2436 |
|
|
2020
Q1 | – | Sell |
-15,150
| Closed | -$88K | – | 2139 |
|
|
2019
Q4 | $88K | Buy |
+15,150
| New | +$88K | ﹤0.01% | 2211 |
|
|
2019
Q3 | – | Sell |
-5,072
| Closed | -$30K | – | 2192 |
|
|
2019
Q2 | $30K | Buy |
+5,072
| New | +$30K | ﹤0.01% | 2364 |
|